Skip to content
All updates
Weekly AI digest

OpenEvidence doubles to $12B; Harvey buys; Krea edits live

1 min readMultra AI Team

Healthcare AI copilot OpenEvidence hits a $12B valuation, Harvey makes its first acquisition, Claude Cowork opens to teams, and Krea brings real-time AI image editing.

A busy week once you look past the megafunding headlines — vertical AI, agents, and creative tools all moved.

OpenEvidence hits a $12B valuation

On January 21, medical AI copilot OpenEvidence ("ChatGPT for doctors") raised a $250M Series D, doubling its valuation to $12B (Thrive Capital, DST Global). It's reportedly used by ~40% of US physicians — a reminder that some of the biggest agent value is deeply vertical.

Harvey's first acquisition

Also January 23, legal-AI leader Harvey acqui-hired Hexus (an AI product-demo/video startup) — its first acquisition, as the well-funded vertical leaders start buying their way into adjacent capabilities.

Krea brings real-time editing

On January 20, Krea shipped Realtime Edit — paint or stream your webcam/screen and watch the AI edit live — alongside its open-weights Krea Realtime 14B real-time video model. Creative tools are collapsing the loop between prompt and result.

Claude Cowork opens to teams

And around January 23, Anthropic expanded Claude Cowork — its desktop "computer agent" for knowledge work — from Max/Pro to Team and Enterprise plans (its full enterprise launch with connectors lands in late February).

What it means if you're picking tools

Vertical AI, research assistants, and creative tools all advanced. See research, image generation, and automation.


Sources: OpenEvidence $12B (CNBC) · Harvey acquires Hexus (TechCrunch) · Krea release notes · Claude Cowork (Fortune)